Amedeo Smart

Free Medical Literature Service

 

Amedeo

Antiretroviral Therapy
  Free Subscription

Articles published in
Pediatr Infect Dis J
    March 2024
  1. GREYBE L, Barnabas S, Cotton M, Rose P, et al
    Cardiometabolic Risk Profiles of Adolescents Living With Perinatally Acquired HIV in South Africa.
    Pediatr Infect Dis J. 2024 Mar 26. doi: 10.1097/INF.0000000000004340.
    >> Share

    February 2024
  2. KENNEALLY AM, Bates BN
    Accidental Raltegravir Overdose in a Neonate: Case Report and Review of Literature.
    Pediatr Infect Dis J. 2024 Feb 6. doi: 10.1097/INF.0000000000004273.
    >> Share

    January 2024
  3. BEKKER A, Yang J, Wang J, Cotton MF, et al
    Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of Age.
    Pediatr Infect Dis J. 2024 Jan 4. doi: 10.1097/INF.0000000000004243.
    >> Share

    November 2023
  4. EPALZA C, Valades-Alcaraz A, Gonzalez-Alba JM, Beltran-Pavez C, et al
    Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain.
    Pediatr Infect Dis J. 2023 Nov 3. doi: 10.1097/INF.0000000000004138.
    >> Share

    July 2023
  5. CHABALA C, Turkova A, Kapasa M, LeBeau K, et al
    Inadequate Lopinavir Concentrations With Modified 8-hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV.
    Pediatr Infect Dis J. 2023 Jul 20. doi: 10.1097/INF.0000000000004047.
    >> Share

    May 2023
  6. NAKIDDU NJ, Bakeera-Kitaka S, Musoke P
    Prevalence and Factors Associated With Delayed Puberty Among Adolescents on Boosted Protease Inhibitor-based Second-line Antiretroviral Therapy: A Cross-sectional Study at a Pediatric Infectious Diseases Clinic in Uganda.
    Pediatr Infect Dis J. 2023;42:407-411.
    >> Share

    March 2023
  7. DENOEUD-NDAM L, Stecker C, Andifasi P, Mushavi A, et al
    Implementation and Uptake of Raltegravir Granules in Newborns Diagnosed With HIV Through Birth Testing in Maternity Settings in Zimbabwe During the COVID-19 Pandemic.
    Pediatr Infect Dis J. 2023 Mar 20. doi: 10.1097/INF.0000000000003906.
    >> Share

    February 2023
  8. BACHA JM, Dlamini S, Anabwani F, Gwimile J, et al
    Realizing the Promise of Dolutegravir in Effectively Treating Children and Adolescents Living With HIV in Real-world Settings in 6 Countries in Eastern and Southern Africa.
    Pediatr Infect Dis J. 2023 Feb 14. doi: 10.1097/INF.0000000000003878.
    >> Share

  9. DODI I, Romanini E, Veronese P, Cangelosi AM, et al
    Highly Active Antiretroviral Therapy in an Extremely Low Birth Weight Newborn With in Utero Transmission of HIV.
    Pediatr Infect Dis J. 2023 Feb 8. doi: 10.1097/INF.0000000000003857.
    >> Share

    October 2022
  10. WANG L, Kourtis AP, Wiener J, Chen L, et al
    Impact of Tenofovir Disoproxil Fumarate Use During Pregnancy on Maternal Bone Mineral Density.
    Pediatr Infect Dis J. 2022 Oct 11. pii: 00006454-990000000-00212.
    >> Share

    August 2022
  11. LIYANAGE M, Nikanjam M, McFadyen L, Vourvahis M, et al
    Maraviroc Population Pharmacokinetics Within the First 6 Weeks of Life.
    Pediatr Infect Dis J. 2022 Aug 9. pii: 00006454-990000000-00156.
    >> Share

    July 2022
  12. STEEGEN K, Levin L, Evans D, Technau KG, et al
    Minimal Cross-resistance to Tenofovir in Children and Adolescents Failing ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment.
    Pediatr Infect Dis J. 2022 Jul 20. pii: 00006454-990000000-00138.
    >> Share

    February 2022
  13. DOLLFUS C, Le Chenadec J, Mandelbrot L, Tubiana R, et al
    Improved Hematologic Outcomes in HIV1-exposed Infants Receiving Nevirapine Compared With Zidovudine for Postnatal Prophylaxis in a High Resource Setting.
    Pediatr Infect Dis J. 2022 Feb 7. pii: 00006454-900000000-95545.
    >> Share

  14. JACOBS TG, van Aerde KJ, Colbers A, Burger DM, et al
    Raltegravir-based Postnatal HIV Prophylaxis Therapy in a Neonate After in Utero Dolutegravir Exposure.
    Pediatr Infect Dis J. 2022;41:131-132.
    >> Share

    December 2021
  15. ILLAN RAMOS M, Soto Sanchez B, Mazariegos Orellana D, Prieto Tato LM, et al
    Safety and Experience With Combined Antiretroviral Prophylaxis in Newborn at High-risk of Perinatal HIV Infection, in a Cohort of Mother Living With HIV-infant Pairs.
    Pediatr Infect Dis J. 2021;40:1096-1100.
    >> Share

    October 2021
  16. MILLS A, Myers L, Raudenbush C, Vossen DA, et al
    A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric Kit and Instructions for Use.
    Pediatr Infect Dis J. 2021 Oct 19. pii: 00006454-900000000-95652.
    >> Share

  17. SINGH RP, Adkison KK, Baker M, Parasrampuria R, et al
    Development of Dolutegravir Single-entity and Fixed-dose Combination Formulations for Children.
    Pediatr Infect Dis J. 2021 Oct 12. pii: 00006454-900000000-95623.
    >> Share

    September 2021
  18. WEYLAND C, Mirani G, Gillespie SL, Paul ME, et al
    A Case of in utero Transmission of Drug-resistant HIV in the United States.
    Pediatr Infect Dis J. 2021 Sep 7. pii: 00006454-900000000-95685.
    >> Share

    May 2021
  19. YEOH DK, Campbell AJ, Bowen AC
    Increase in Body Mass Index in Children With HIV, Switched to Tenofovir Alafenamide Fumarate or Dolutegravir Containing Antiretroviral Regimens.
    Pediatr Infect Dis J. 2021;40:e215-e216.
    >> Share

  20. MANGOLD JF, Goswami R, Nelson AN, Martinez DR, et al
    Maternal Intervention to Prevent Mother-to-Child Transmission of HIV: Moving Beyond Antiretroviral Therapy.
    Pediatr Infect Dis J. 2021;40.
    >> Share

    April 2021
  21. NESHEIM SR, Balaji A, Hu X, Lampe M, et al
    Opportunistic Illnesses in Children With HIV Infection in the United States, 1997-2016.
    Pediatr Infect Dis J. 2021 Apr 21. doi: 10.1097/INF.0000000000003154.
    >> Share

  22. HIRT D, Kubota Kilengelela J, Jarreau PH, Treluyer JM, et al
    Nevirapine Pharmacokinetics in Neonates Between 25 and 32 Weeks Gestational Age for the Prevention of Mother-to-Child Transmission of HIV.
    Pediatr Infect Dis J. 2021;40:344-346.
    >> Share

    January 2021
  23. OWOR M, Tierney C, Ziemba L, Browning R, et al
    Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092.
    Pediatr Infect Dis J. 2021 Jan 12. pii: 00006454-900000000-95911.
    >> Share

  24. WEXLER C, Maloba M, Goggin K, Kale SB, et al
    ART Initiation for Infants Diagnosed With HIV Through Point of Care and Conventional Polymerase Chain Reaction Testing in Kenya: A Case Series.
    Pediatr Infect Dis J. 2021 Jan 12. pii: 00006454-900000000-95902.
    >> Share

    November 2020
  25. BHATTACHARYA D, Guo R, Tseng CH, Emel L, et al
    Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living With HIV and HBV.
    Pediatr Infect Dis J. 2020 Nov 11. doi: 10.1097/INF.0000000000002980.
    >> Share

    September 2020
  26. PATEL F, Shiau S, Strehlau R, Shen Y, et al
    Low Pretreatment Viral Loads in Infants With HIV in an Era of High-maternal Antiretroviral Therapy Coverage.
    Pediatr Infect Dis J. 2020 Sep 7. doi: 10.1097/INF.0000000000002897.
    >> Share

  27. TADESSE BT, Foster BA, Latour E, Lim JY, et al
    Predictors of Virologic Failure Among a Cohort of HIV-infected Children in Southern Ethiopia.
    Pediatr Infect Dis J. 2020 Sep 7. doi: 10.1097/INF.0000000000002898.
    >> Share

    July 2020
  28. PEREZ-HERAS I, Fernandez-Escobar V, Del Pozo-Carlavilla M, Diaz-Merchan R, et al
    Two Cases of SARS-CoV-2 Infection in Pediatric Oncohematologic Patients in Spain.
    Pediatr Infect Dis J. 2020 Jul 28. doi: 10.1097/INF.0000000000002841.
    >> Share

  29. BAI K, Liu W, Liu C, Fu Y, et al
    Clinical Analysis of 25 COVID-19 Infections in Children.
    Pediatr Infect Dis J. 2020;39:e100-e103.
    >> Share

    June 2020
  30. DIACK A, Yonaba C, Coulibaly A, Ouedraogo S, et al
    Progressive Decline of the Glomerular Filtration Rate in HIV-infected Children Treated With Tenofovir Disoproxil Fumarate-based Regimens in West and Central Africa.
    Pediatr Infect Dis J. 2020 Jun 3. doi: 10.1097/INF.0000000000002733.
    >> Share

  31. VALLILO NG, Durigon GS, Lianza AC, de Fatima Rodrigues Diniz M, et al
    Echocardiographic Follow-up of Perinatally HIV-infected Children and Adolescents: Results From a Single-center Retrospective Cohort Study in Brazil.
    Pediatr Infect Dis J. 2020;39:526-532.
    >> Share

    May 2020
  32. BAI K, Liu W, Liu C, Fu Y, et al
    Clinical Analysis of 25 Novel Coronavirus Infections in Children.
    Pediatr Infect Dis J. 2020 May 12. doi: 10.1097/INF.0000000000002740.
    >> Share

  33. QIU L, Jiao R, Zhang A, Chen X, et al
    A Typical Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes.
    Pediatr Infect Dis J. 2020 May 1. doi: 10.1097/INF.0000000000002720.
    >> Share

    February 2020
  34. BUCHHOLZ B, Niehues T
    Lost in Transition: A Risk Factor for Mortality in Youth Living With HIV.
    Pediatr Infect Dis J. 2020;39:e14-e16.
    >> Share

    January 2020
  35. ARCHARY M, Zanoni B, Lallemant M, Suwannaprom P, et al
    Acceptability and Feasibility of Using Raltegravir Oral Granules for the Treatment of Neonates in a Low-resource Setting.
    Pediatr Infect Dis J. 2020;39:57-60.
    >> Share

    November 2019
  36. IYUN V, Technau KG, Eley B, Rabie H, et al
    Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006-2017.
    Pediatr Infect Dis J. 2019 Nov 5. doi: 10.1097/INF.0000000000002516.
    >> Share

  37. RODRIGUEZ CA, Kolevic L, Ramos A, Wong M, et al
    Lifetime Changes in CD4 T-cell count, Viral Load Suppression and Adherence Among Adolescents Living With HIV in Urban Peru.
    Pediatr Infect Dis J. 2019 Nov 4. doi: 10.1097/INF.0000000000002501.
    >> Share

  38. SANDBULTE MR, Nazir N, Goggin K, Wexler C, et al
    Predictors of Mortality Among HIV-exposed Infants Through 18 Months of Age in Kenya: A Retrospective Review of Programmatic Data.
    Pediatr Infect Dis J. 2019 Nov 4. doi: 10.1097/INF.0000000000002511.
    >> Share

    April 2019
  39. MILLAR JR, Mvo Z, Bengu N, Fillis R, et al
    Increasing Diagnostic Uncertainties in Children With In Utero HIV Infection.
    Pediatr Infect Dis J. 2019 Apr 23. doi: 10.1097/INF.0000000000002315.
    >> Share

    February 2019
  40. DOW DE, Shayo AM, Cunningham CK, Mmbaga B, et al
    HIV-1 Drug Resistance and Virologic Outcomes Among Tanzanian Youth Living with HIV.
    Pediatr Infect Dis J. 2019 Feb 4. doi: 10.1097/INF.0000000000002288.
    >> Share

    September 2018
  41. BARTLETT AW, Mohamed TJ, Sudjaritruk T, Kurniati N, et al
    Disease- and Treatment-Related Morbidity in Adolescents With Perinatal HIV Infection in Asia.
    Pediatr Infect Dis J. 2018 Sep 29. doi: 10.1097/INF.0000000000002208.
    >> Share

    August 2018
  42. BLIGNAUT E, Rossouw TM, Becker PJ, Mavuso DS, et al
    Gingival Recession and Localized Aggressive Periodontitis Among HIV-Infected Children and Adolescents Receiving Antiretroviral Therapy.
    Pediatr Infect Dis J. 2018 Aug 9. doi: 10.1097/INF.0000000000002166.
    >> Share

    May 2018
  43. NSANZIMANA S, McArdle F, Remera E, Mulindabigwi A, et al
    Viral Suppression in a Nationwide Sample of HIV-infected Children on Antiretroviral Therapy in Rwanda.
    Pediatr Infect Dis J. 2018 May 21. doi: 10.1097/INF.0000000000002101.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016